Fig. 6 | Scientific Reports

Fig. 6

From: Studying the efficacy of JBOL volatile components in idiopathic pulmonary fibrosis (IPF) using GC-MS and network pharmacology

Fig. 6

Schematic representation of docking (A: Molecular docking modeling of STAT3 with Senkyunolide H; B: Molecular docking modeling of SRC with Senkyunolide I; C: Molecular docking modeling of EGFR with 4-terpineol; D: Molecular docking modeling of EGFR with α-Terpineol; E: Molecular docking modeling of STAT3 with Sedanolide; F: Molecular docking modeling of STAT3 with Ligustilide).

Back to article page